Burzynski Research Institute, Inc. Share Price
Equities
BZYR
US1231591058
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0428 USD | +2.32% | -.--% | -2.73% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 4.83M 403M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net cash position 2022 | 3.38K 282K | Net cash position 2023 | 934 77.96K | EV / Sales 2023 | - |
P/E ratio 2022 |
-3
x | P/E ratio 2023 |
-3.68
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 18.99% |
1 day | +2.32% | ||
1 month | +76.13% | ||
3 months | +42.67% | ||
6 months | -4.89% | ||
Current year | -2.73% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 01/84/01 | |
Director of Finance/CFO | 46 | 01/12/01 | |
Tomasz Janicki
PRN | Corporate Officer/Principal | 58 | 01/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 01/84/01 | |
Director/Board Member | 44 | 08/11/08 | |
Director/Board Member | 60 | 06/21/06 |
1st Jan change | Capi. | |
---|---|---|
-2.73% | 5.62M | |
+20.79% | 47.9B | |
+46.56% | 41.42B | |
-2.61% | 40.7B | |
-6.20% | 28.92B | |
+10.21% | 25.55B | |
-21.83% | 19.27B | |
-2.00% | 12.15B | |
+30.77% | 12.14B | |
-0.82% | 11.99B |
- Stock Market
- Equities
- BZYR Stock